Safety of 131I-Rituximab Outpatient Radioimmunotherapy of Non-Hodgkin Lymphoma

被引：0
|
作者：
Calais, P. J.
Turner, J. H.
机构：
来源：
MEDICAL PHYSICS | 2011年 / 38卷 / 06期
关键词：
D O I：
10.1118/1.3611898
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
SU-E-J-131
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Outpatient 131I-Rituximab Radioimmunotherapy for Non-Hodgkin Lymphoma A Study in Safety
    Calais, Phillipe J.
    Turner, John Harvey
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (08) : 732 - 737
  • [2] Personalized Dosimetry of 131I-Rituximab Radioimmunotherapy of Non-Hodgkin Lymphoma Defined by Pharmacokinetics in Bone Marrow and Blood
    Boucek, Jan A.
    Turner, J. Harvey
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2014, 29 (01) : 18 - 25
  • [3] Radioimmunotherapy with 131I-rituximab for patients with relapsed/refractory B-cell non-Hodgkin's lymphoma (NHL)
    Kang, Hye J.
    Lee, Seung S.
    Kim, Kyeong M.
    Choi, Tae H.
    Cheon, Gi J.
    Kim, Won S.
    Suh, Cheolwon
    Yang, Sung H.
    Lim, Sang M.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 (02) : 136 - +
  • [4] Personalized dosimetry of 131I-rituximab radioimmunotherapy of lymphoma
    Boucek, J. A.
    Turner, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S261 - S262
  • [5] Clinical scale preparation and evaluation of 131I-Rituximab for Non-Hodgkin's Lymphoma
    Kameswaran, Mythili
    Vimalnath, K. Viswanathan
    Rajeswari, Ardhi
    Joshi, Prahlad Vasudeo
    Sarma, H. D.
    Samuel, Grace
    RADIOCHIMICA ACTA, 2014, 102 (06) : 553 - 560
  • [6] Tandem myeloablative 131I-rituximab radioimmunotherapy and high-dose chemotherapy in refractory/relapsed non-Hodgkin lymphoma patients
    Deshayes, Emmanuel
    Kraeber-Bodere, Francoise
    Vuillez, Jean-Philippe
    Bardies, Manuel
    Teulon, Isabelle
    Pouget, Jean-Pierre
    IMMUNOTHERAPY, 2013, 5 (12) : 1283 - 1286
  • [7] Radioimmunotherapy using 131I-rituximab in patients with advanced stage B-cell non-Hodgkin’s lymphoma: initial experience
    Maren Bienert
    Ingrid Reisinger
    Stefanie Srock
    Beatrice I Humplik
    Christel Reim
    Thomas Kroessin
    Norbert Avril
    Antonio Pezzutto
    Dieter L Munz
    European Journal of Nuclear Medicine and Molecular Imaging, 2005, 32 : 1225 - 1233
  • [8] Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma
    Kang, Hye Jin
    Lee, Seung-Sook
    Byun, Byung Hyun
    Kim, Kyeong Min
    Lim, Ilhan
    Choi, Chang Woon
    Suh, Cheolwon
    Kim, Won Seog
    Nam, Seung-Hyun
    Lee, Soon Il
    Eom, Hyeon Seok
    Shin, Dong-Yeop
    Lim, Sang Moo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (04) : 945 - 953
  • [9] Repeated radioimmunotherapy with 131I-rituximab for patients with low-grade and aggressive relapsed or refractory B cell non-Hodgkin lymphoma
    Hye Jin Kang
    Seung-Sook Lee
    Byung Hyun Byun
    Kyeong Min Kim
    Ilhan Lim
    Chang Woon Choi
    Cheolwon Suh
    Won Seog Kim
    Seung-Hyun Nam
    Soon Il Lee
    Hyeon Seok Eom
    Dong-Yeop Shin
    Sang Moo Lim
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 945 - 953
  • [10] Radioimmunotherapy using 131I-rituximab in patients with advanced stage B-cell non-Hodgkin's lymphoma:: initial experience
    Bienert, M
    Reisinger, I
    Srock, S
    Humplik, BI
    Reim, C
    Kroessin, T
    Avril, N
    Pezzutto, A
    Munz, DL
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 (10) : 1225 - 1233
12345